// App-Quantinova.ai

87 : Comparison of Baseline Characteristics of Rheumatoid Arthritis Patients Initiating Therapy with Subcutaneous Golimumab and Infliximab and Intravenous Golimumab: An Analysis from the Prospective, Observational Registry, BioTRAC

Researchers

Presenter

  • Wojciech Olszynski

Principal Investigators

  • Andrew Chow

  • Brendan Osborne

  • Milton Baker

  • Boulos Haraoui

  • Angeliki Karellis

  • Eliofotisti Psaradellis

  • Francois Nantel

  • Allen Lehman

  • Cathy Tkaczyk

  • Karina Maslova

Medical Centers

  • Credit Valley Rheumatology, Mississauga, ON, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

  • University of Victoria, Victoria, BC, Canada

  • Institut de Rhumatologie, Montreal, QC, Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved